MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

2024 International Congress

September 27-October 1, 2024. Philadelphia, PA.

View by Title View Categories
Jump to:  [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z
  • NouvNeu001, A Phase 1 Stage Chemically Induced Human Dopaminergic Progenitor Cell Therapy for the Treatment of Mid- to Late-stage Parkinson’s Disease

    M. Cai, J. Wei, X. Ren, R. Yan, H. Chen, N. Xiong (Wuhan, China)

  • Novel ASO Targeting IGHMBP2 Cryptic Splice Variant: Efficacy and Safety

    S. Smieszek, B. Przychodzen, C. Tyner, C. Johnson, C. Polymeropoulos, G. Birznieks, M. Polymeropoulos (Washington, USA)

  • Novel In-Clinic Use of Levodopa Inhalation Powder (CVT-301) as an Outpatient Diagnostic Tool for Parkinson’s Disease

    Z. Afshari, N. Nguyen, M. Afshari (Glenview, USA)

  • Novel Partial Gene Deletion in CaCNA1A Presenting with Gait Ataxia, Vertigo, and Abnormal Eye Movements

    D. Mohanty, I. Bledsoe (San Francisco, USA)

  • Nutritional Status Implication at 6 Months in Parkinson’s Disease: Follow-Up Results

    N. Ayo Mentxakatorre, B. Tijero, T. Fernandez-Valle, A. Ortiz-de-Echevarria, M. Acera Gil, I. Chavarri Rubio, C. Juanes Moreno, M. Ruiz-Lopez, JC. Gomez-Esteban, R. Del Pino (Barakaldo, Spain)

  • Obsessive-Compulsive Disorder Prevalence in Parkinson’s Disease Caregivers

    F. Hojjatipour, M. Salari (tehran, Islamic Republic of Iran)

  • Oculomotor Biomarkers for Cerebellar Ataxia and Severity in Smooth Pursuit

    P. Ponger, G. Gurevich, R. Alcalay, Y. Bonneh, S. Shani (Tel Aviv, Israel)

  • Odor-specific symptoms in Parkinson’s disease – UPSIT odor identification status versus clinical severity.

    YG. Guo, SC. Chiu (Taichung, Taiwan)

  • Once-Daily Suvecaltamide Pharmacokinetics, Safety, & Tolerability–Phase 1, Randomized, Double-Blind, Multiple Ascending Dose Study

    S. Markova, M. Baladi, M. Lee, C. Chen (Palo Alto, USA)

  • One dose fits all? An analysis of the levodopa equivalent dose over time in Parkinson’s disease

    V. Lavu, J. Dwarampudi, Q. Yuan, F. Sarmento, T. de Araujo, V. Garg, J. Wong (Gainesville, USA)

  • « Previous Page
  • 1
  • …
  • 115
  • 116
  • 117
  • 118
  • 119
  • …
  • 181
  • Next Page »
Jump to:  [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley